A Single-Dose, Open-Label, Randomized, 4-Way Crossover Study to Assess the Effect of Timing of Food Intake on the Pharmacokinetics of Abiraterone Following Single-Dose Administration of Abiraterone Acetate Tablets in Healthy Caucasian and Japanese Male Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2015
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics
- 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jun 2012 Actual patient number (51) added as reported by ClinicalTrials.gov.
- 04 May 2012 Planned End Date changed from 1 Apr 2012 to 1 May 2012 as reported by ClinicalTrials.gov.